University of Wisconsin–Madison

UW ICTR Receives 3rd Consecutive CTSA Grant from NIH

The leadership and staff of the University of Wisconsin Institute for Clinical and Translational Research (UW ICTR) are delighted to announce the receipt of a five-year renewal of their Clinical and Translational Science Award (CTSA) from NIH. This award of $39,876,488, from the National Center for Advancing Translational Sciences (NCATS), represents the ongoing excellence of the training programs and infrastructure support initiatives that ICTR underwrites to advance clinical and translational science at UW-Madison, Marshfield Clinic, and statewide.

UW ICTR is a partnership of four health sciences schools (Medicine and Public Health, Nursing, Pharmacy, and Veterinary Medicine) and a college (Engineering) in Madison and the Marshfield Clinic in Marshfield, WI, one of the largest private, multispecialty group practices in the United States. The institute was founded in 2007 and this award initiates the third funding cycle. In addition to ICTR, the CTSA consortium encompasses 64 (57 of which are currently funded) sites across the United States.

Marc Drezner, SMPH Senior Associate Dean for Clinical and Translational Research and Executive Director of ICTR comments,

Marc Drezner

As many people say, ‘it takes a village.’ Our success in receiving this renewal is reflective of our superb faculty and staff, as well as the institutional support we receive from many sources. ICTR succeeds because we have one of the most intensely dedicated local environments in the national CTSA consortium.

At our recent external advisory committee meeting, our reviewers applauded investments made by campus partners and leadership. Thank you!

The mission of ICTR is to support the transformation of research into a translational continuum from investigation through discovery and into community practice, thereby linking basic research to practical improvements in human health. Indeed, Robert N. Golden, Dean of the School of Medicine and Public Health and Vice-Chancellor for Medical Affairs, notes,

We are so grateful for the outstanding leadership of this wonderful institute, and the outstanding partnerships that it has created, all aimed at advancing the health of the people of Wisconsin.

Rob Lemanske, ICTR Deputy Executive Director, explains,

Rob Lemanske

ICTR uses a three-fold approach to achieve our mission. First, we provide career training for investigators and trainees at all levels to promote the development of the future workforce in clinical and translational research. Second, our very successful pilot awards program, now in its eleventh year, provides seed money and research mentoring for research areas spanning the translational spectrum. Finally, ICTR also supports an extensive array of shared services and infrastructure necessary for the conduct of translational research. These range from resources for clinical research, consultations in biostatistics and bioinformatics, to tools and partners for stakeholder-engaged research and dissemination & implementation research.

We’re also excited about the innovations we have planned for the coming years, which our grant renewal will make possible. These fronts include refining our offerings for strategic recruitment of research participants, expanding investigator training in engaging special populations in research, and supporting cutting-edge bioinformatics research for predictive medical analytics.

For more information about ICTR visit ictr.wisc.edu online or email join-ictr_news@lists.wisc.edu to be added to our mailing list for eNewsletters and major announcements.